1. Initial treatment efficacy and safety of durvalumab plus tremelimumab combination therapy in unresectable hepatocellular carcinoma in clinical practice
   Tetsu Tomonari et al, 2024, JGH Open CrossRef
2. Advances in systemic therapy leading to conversion surgery for advanced hepatocellular carcinoma
   Hiroyuki Hakoda et al, 2024, BST CrossRef
3. Antitumor effects and immune‐mediated adverse events of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma
   Takanori Ito et al, 2024, Hepatology Research CrossRef